Letrozole(Femara)
CAS No: 112809-51-5
Molecular formula: C17H11N5
Molecular weight: 285.3
Appearance: White power
Assay: 99 percent
Delivery time: 5-7working days door to door
Minimum order: 1g
Supply ability: 100kg/month
Quality standard: USP32 Detail:
Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.
Letrozole is intended for use only by women who are no longer of childbearing age. Possible candidates must have already ceased to menstruate. It is often used in patients who have already undergone other cancer treatments, such as radiation, chemotherapy, and used other cancer drugs, like tamoxifen. This nonsteroidal aromatase inhibitor may help prevent any remaining cancer cells from spreading.
Hugeraw Health Technology Co.,Ltd.is one of the biggest manufacturers of Steroid Raw Powders , Growth and other hormones in Taizhou, China with GMP standard .Equipped with advanced production and detection equipment , all goods are of highest purity(98% +) and quality . We use the most experienced shipping agent and choose the safest method according to your shipping address . In case package be stopped by accident, we guarantee timely reshipping .
Hugeraw is fixed supplier of many distributo...
View more >>
Basic Information
Business Type: Manufacturer
Product/Service (We Buy): 11 - 50 People
Ownership Type: LLC (Ltd Liability Corp)
Registered Capital: US$501 Thousand - US$1 Million
Year Established: 2009
Number of Employees: 11 - 50 People
Trade & Market
Main Markets: North America,Southeast Asia,Mid East,South America,Africa,Eastern Asia,Eastern Europe,Oceania,Western Europe
QA/QC: In House
Number of Production Lines: 4
Number of R&D Staff: 98
Number of QC Staff: 11 - 20 People
Total Annual Sales Volume: US$2.5 Million - US$5 Million
China
